Biopsy Devices Market - Global Forecast to 2030
商品番号 : SMB-45513
出版社 | MarketsandMarkets |
出版年月 | 2025年3月 |
ページ数 | 504 |
図表数 | 777 |
価格タイプ | シングルユーザライセンス |
価格 | USD 4,950 |
種別 | 英文調査報告書 |
Report Overview
The global biopsy device market is projected to reach USD 11.01 billion by 2030 from USD 7.27 billion in 2024, at a CAGR of 7.2% during the forecast period.
世界の生検装置市場は、予測期間中に年平均成長率 7.2% で成長し、2024 年の 72 億 7,000 万米ドルから 2030 年には 110 億 1,000 万米ドルに達すると予測されています。

One of the biggest drivers is the growing incidence of cancer, especially breast, lung, and prostate cancers, which need precise and early diagnostic tests. The World Health Organization states that cancer cases are likely to increase substantially by 2030. Therefore, there would be an increasing demand for biopsy devices. Also, the growing demand for less invasive procedures is driving market growth further. The newer biopsy methods like vacuum-assisted and liquid biopsies are more accurate, have lower recovery times, and cause lower patient discomfort Furthermore, advances in technology, such as robotic-assisted biopsy machines, AI-based diagnostic systems, and image-guided biopsy procedures, improve accuracy and efficiency, driving market growth further. Moreover, rising government programs for cancer screening, combined with rising healthcare spending, especially in developing nations, drive the market forward. Nonetheless, the high prices of sophisticated biopsy devices and strict regulatory environments can serve as constraints.
最大の推進力の1つは、正確で早期の診断検査を必要とするがん、特に乳がん、肺がん、前立腺がんの発生率の増加です。世界保健機関は、がん症例は2030年までに大幅に増加する可能性があると述べています。したがって、生検装置の需要が増加するでしょう。また、低侵襲性処置の需要の高まりも、市場の成長をさらに促進しています。真空支援生検や液体生検などの新しい生検方法は、より正確で、回復時間が短く、患者の不快感が少ないです。さらに、ロボット支援生検機器、AIベースの診断システム、画像誘導生検手順などの技術の進歩により、精度と効率が向上し、市場の成長がさらに促進されています。さらに、がんスクリーニングのための政府プログラムの増加と、特に発展途上国での医療費の増加が市場を前進させています。とはいえ、高度な生検装置の高価格と厳格な規制環境が制約となる可能性があります。
“The needle-based biopsy instrument segment to grow the fastest during the forecast period.”
Based on the product, the biopsy device market is divided into Needle-based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and Robotic biopsy device. Among these, in 2023, Needle-based biopsy instrument segment account for the highest growing segment of 7.8% in biopsy device market. This is due to rising preference for the utilization of minimally invasive diagnostic interventions. The Needle biopsy devices such as core needle biopsy (CNB), fine needle aspiration biopsy (FNAB), and vacuum-assisted biopsy (VAB) devices provide a less painful and less invasive alternative to surgical biopsies. This lowers patient pain, recovery time, and procedural expenses. Moreover, the growing focus on early disease detection and precision medicine has also driven demand for needle biopsies, as they yield very accurate tissue samples with few complications. Further, the increasing trend towards ambulatory and outpatient facilities for biopsies has also increased the market, as needle biopsies are quick and require little infrastructure. However, the risks of bleeding, infection, and sampling errors pose challenges to the growth of this market.
“The gastroenterology segment accounts for the second largest market share in biopsy device market.”
Based on application, the biopsy device market is segmented into oncology, Gastroenterology, Bone & Bone marrow biopsy and other applications. The gastroenterology segment accounts for the second largest market share in biopsy device market. This can be attributed to the growing cased of gastrointestinal (GI) diseases and technological advancements in endoscopic biopsy methods. Moreover, the GI disorders such as Colorectal cancer, gastric cancer, inflammatory bowel disease (IBD), celiac disease, and gastrointestinal infections need biopsy procedures for proper diagnosis. Further, the increasing incidence of colorectal cancer, one of the most recurrently diagnosed cancers globally, makes a major contribution to the need for GI biopsy devices. Furthermore, the growing use of image-guided biopsy methods, namely endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), improves diagnostic accuracy in deep-seated GI tumors, contributing to market growth. Moreover, rise in geriatric population suffering from GI disorders and advancements in healthcare infrastructure on a worldwide level favour market growth.

“Asia Pacific accounted for the fastest growing of the biopsy device market by region.”
The global biopsy device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for the biopsy device and is estimated to grow at the highest CAGR during the forecast period. The increasing incidence of cancer, coupled by demographic changes and lifestyle factors, has increased the need for early diagnosis, driving the use of biopsy procedures. Development of healthcare infrastructure, especially in nations such as China, India, and Japan, has increased access to sophisticated diagnostic technologies. Further, government initiatives and rising healthcare expenditures have also aided cancer screening programs, stimulating market growth. Moreover, the growing medical tourism industry in the region, specifically in countries with low-cost yet high-quality biopsy services, has also increased the growth in demand.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–45%, Tier 2–30%, and Tier 3– 25%
- By Designation: C-level–35%, Director-level–25% and Others–40%
- By Region: North America–40%, Europe–20%, Asia Pacific–25%, Latin America- 10%, and Middle east and Africa-5%
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the biopsy device market are BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B.Braun SE ( Germany), Hologic,Inc (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services,Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India).

Research Coverage
This report studies the biopsy device market based on product, type, technology, application end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Analysis of Key divers (Rising prevalence of cancer), restraints (Increasing product recalls), Challenge (Technological advancements), opportunity (Underdeveloped healthcare infrastructure in emerging economies)
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the bbiopsy device market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the biopsy device market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the biopsy devices market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 STUDY SCOPE 43
1.3.1 MARKET SEGMENTATION & GEOGRAPHIC SPREAD 43
1.3.2 INCLUSIONS & EXCLUSIONS 44
1.4 YEARS CONSIDERED 45
1.5 CURRENCY CONSIDERED 45
1.6 STAKEHOLDERS 46
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
2.1.1 SECONDARY DATA 48
2.1.1.1 Key data from secondary sources 49
2.1.2 PRIMARY DATA 49
2.1.2.1 Key data from primary sources 51
2.1.2.2 Key industry insights 51
2.2 MARKET SIZE ESTIMATION 52
2.3 ASSESSMENT OF MARKET SEGMENTS 56
2.4 ASSESSMENT OF GEOGRAPHIC SEGMENTS 56
2.5 MARKET BREAKDOWN & DATA TRIANGULATION 56
2.6 RESEARCH ASSUMPTIONS 57
2.7 RESEARCH LIMITATIONS 58
2.7.1 METHODOLOGY-RELATED LIMITATIONS 58
2.7.2 SCOPE-RELATED LIMITATIONS 58
2.8 RISK ASSESSMENT 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 64
4.1 OPPORTUNITIES FOR PLAYERS IN BIOPSY DEVICES MARKET 64
4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER 65
4.3 BIOPSY DEVICES MARKET: GEOGRAPHIC SNAPSHOT 66
4.4 BIOPSY DEVICES MARKET: GEOGRAPHIC MIX 67
4.5 BIOPSY DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS,
2024 VS. 2030 (USD MILLION) 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
5.2.1 DRIVERS 69
5.2.1.1 Rising prevalence of cancer 69
5.2.1.2 Increasing preference for minimally invasive surgeries 69
5.2.1.3 Initiatives undertaken by governments and global health organizations 69
5.2.1.4 Increased number of hospitals and diagnostic centers 70
5.2.1.5 Improved reimbursement policies 70
5.2.2 RESTRAINTS 71
5.2.2.1 Increasing product recalls 71
5.2.2.2 High risk of infections 71
5.2.3 OPPORTUNITIES 71
5.2.3.1 Technological advancements 71
5.2.3.2 Growing investments in emerging economies 72
5.2.4 CHALLENGES 72
5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies 72
5.3 INDUSTRY TRENDS 72
5.3.1 MINIMALLY INVASIVE PROCEDURES 73
5.3.2 ROBOTIC-ASSISTED BIOPSY DEVICES 73
5.3.3 LIQUID BIOPSY TECHNOLOGY 74
5.4 TECHNOLOGY ANALYSIS 74
5.4.1 KEY TECHNOLOGIES 74
5.4.1.1 Robotic-assisted biopsy devices 74
5.4.1.2 Optical biopsy technologies 75
5.4.1.3 Minimally invasive biopsy devices 75
5.4.2 COMPLEMENTARY TECHNOLOGIES 75
5.4.2.1 Imaging technologies 75
5.4.2.2 Tissue analysis technologies 76
5.4.2.3 Artificial intelligence 76
5.4.3 ADJACENT TECHNOLOGIES 77
5.4.3.1 Digital pathology and AI integration 77
5.4.3.2 Precision medicine tools 77
5.4.3.3 Advanced needle and probe technologies 77
5.5 PORTER’S FIVE FORCES ANALYSIS 78
5.5.1 THREAT FROM NEW ENTRANTS 78
5.5.2 BARGAINING POWER OF SUPPLIERS 78
5.5.3 BARGAINING POWER OF BUYERS 79
5.5.4 THREAT FROM SUBSTITUTES 79
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.6 REGULATORY LANDSCAPE 80
5.6.1 REGULATIONS, BY REGION 80
5.6.1.1 North America 80
5.6.1.1.1 US 80
5.6.1.1.2 Canada 80
5.6.1.2 Europe 81
5.6.1.3 Asia Pacific 81
5.6.1.4 Latin America 81
5.6.1.5 Middle East & Africa 82
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.7 PATENT ANALYSIS 85
5.7.1 PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET 85
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 85
5.8 TRADE ANALYSIS 88
5.9 PRICING ANALYSIS 89
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT 89
5.9.2 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION 90
5.10 KEY CONFERENCES & EVENTS 90
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 91
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
5.11.2 BUYING CRITERIA 92
5.12 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS 93
5.13 ECOSYSTEM ANALYSIS 94
5.14 CASE STUDY ANALYSIS 95
5.14.1 CASE STUDY 1: DEVICELAB COLLABORATED WITH CLINICAL EXPERTS TO IDENTIFY LIMITATIONS OF EXISTING BREAST BIOPSY PROCEDURES 95
5.14.2 CASE STUDY 2: RESEARCHERS AT UNIVERSITY OF TWENTE DESIGNED ROBOTIC SETUP AND SOFTWARE ARCHITECTURE TO ASSIST RADIOLOGISTS IN TARGETING MRI-DETECTED SUSPICIOUS TUMORS 96
5.14.3 CASE STUDY 3: RESEARCH TEAM DESIGNED FLEXIBLE ROBOTIC SYSTEM FOR BIOPSY SAMPLING APPLIED TO HUMAN CORPSES PLACED INSIDE PROTECTIVE BODY BAGS 96
5.15 SUPPLY CHAIN ANALYSIS 97
5.16 ADJACENT MARKET ANALYSIS 99
5.16.1 BREAST BIOPSY DEVICES MARKET 99
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 100
5.18 INVESTMENT & FUNDING SCENARIO 101
5.19 IMPACT OF AI ON BIOPSY DEVICES MARKET 101
6 BIOPSY DEVICES MARKET, BY PRODUCT 103
6.1 INTRODUCTION 104
6.2 NEEDLE-BASED BIOPSY INSTRUMENT 105
6.2.1 CORE NEEDLE BIOPSY 107
6.2.1.1 Core needle biopsy device 110
6.2.1.1.1 Semi-automatic 114
6.2.1.1.1.1 Need for balance of user control and automated functionality in procedures to drive market 114
6.2.1.1.2 Automatic 116
6.2.1.1.2.1 Demand for efficiency and accuracy in biopsy procedures to boost growth 116
6.2.1.2 Core needle biopsy needle 118
6.2.1.2.1 Disposable 121
6.2.1.2.1.1 Need for infection control and safety concerns to boost growth 121
6.2.1.2.2 Reusable 123
6.2.1.2.2.1 Cost-effectiveness of reusable core biopsy needles to drive market 123
6.2.2 FINE NEEDLE ASPIRATION BIOPSY 125
6.2.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market 125
6.2.3 VACUUM-ASSISTED BIOPSY 128
6.2.3.1 Increasing need for early and accurate cancer detection to drive market 128
6.3 VISUALIZATION DEVICE/SYSTEM 131
6.3.1 RISING PREVALENCE OF CANCER AND OTHER CHRONIC CONDITIONS
TO DRIVE DEMAND FOR VISUALIZATION DEVICE 131
6.4 BRUSH BIOPSY INSTRUMENT 133
6.4.1 PREFERENCE FOR MINIMALLY INVASIVE BIOPSY PROCEDURES
TO BOOST MARKET 133
6.5 BIOPSY ACCESSORY 135
6.5.1 BIOPSY FORECEP 138
6.5.1.1 General biopsy forcep 141
6.5.1.1.1 Demand for minimally invasive procedures and precise diagnostics to surge growth 141
6.5.1.2 Hot biopsy forecep 143
6.5.1.2.1 Unique ability of hot biopsy forecep to cut and coagulate tissue to support growth 143
6.5.2 TISSUE MARKER 145
6.5.2.1 Rising cases of breast cancer to boost market growth 145
6.5.3 LOCALIZATION WIRE 147
6.5.3.1 Ability of localization wire to detect precise target locations to drive growth 147
6.5.4 OTHER ACCESSORIES 150
6.6 ROBOTIC BIOPSY DEVICE 151
6.6.1 RAPID DEVELOPMENT OF ROBOTIC BIOPSY DEVICES TO BOOST GROWTH 151
7 BIOPSY DEVICES MARKET, BY TECHNOLOGY 154
7.1 INTRODUCTION 155
7.2 ULTRASOUND-GUIDED BIOPSY 155
7.2.1 ULTRASOUND GUIDANCE ENHANCES SAFETY, MINIMIZES COMPLICATIONS, AND IMPROVES DIAGNOSTIC ACCURACY 155
7.3 STEREOTACTIC-GUIDED BIOPSY 157
7.3.1 NEED FOR EFFICIENT AND ACCURATE BIOPSY PROCEDURES
TO SUPPORT MARKET GROWTH 157
7.4 OTHER TECHNOLOGIES 159
8 BIOPSY DEVICES MARKET, BY APPLICATION 162
8.1 INTRODUCTION 163
8.2 ONCOLOGY 164
8.2.1 BREAST CANCER 166
8.2.1.1 Increasing demand for early and accurate diagnosis to boost growth 166
8.2.2 SOFT TISSUE CANCER 168
8.2.2.1 Advancements in diagnostics and growing emphasis on cancer therapeutics to drive market 168
8.3 GASTROENTEROLOGY 170
8.3.1 RISING INCIDENCE OF GASTROINTESTINAL DISEASES TO DRIVE MARKET 170
8.4 BONE & BONE MARROW BIOPSY 172
8.4.1 RISING EMPHASIS ON BONE MARROW BIOPSIES
TO SUPPORT MARKET GROWTH 172
8.5 OTHER APPLICATIONS 175
9 BIOPSY DEVICES MARKET, BY END USER 177
9.1 INTRODUCTION 178
9.2 HOSPITALS & BREAST CARE CENTERS 179
9.2.1 DEMAND FOR STATE-OF-THE-ART BIOPSY FACILITIES TO DRIVE MARKET 179
9.3 DIAGNOSTIC IMAGING CENTERS 182
9.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS
TO SUPPORT MARKET GROWTH 182
9.4 AMBULATORY SURGICAL CENTERS 184
9.4.1 GROWING FOCUS ON AMBULATORY CARE TO DRIVE MARKET 184
9.5 OTHER END USERS 187
10 BIOPSY DEVICES MARKET, BY REGION 189
10.1 INTRODUCTION 190
10.2 NORTH AMERICA 193
10.2.1 MACROECONOMIC OUTLOOK 193
10.2.2 US 203
10.2.2.1 Growth in elderly population to drive market 203
10.2.3 CANADA 212
10.2.3.1 Rising government investments to drive growth 212
10.3 EUROPE 220
10.3.1 MACROECONOMIC OUTLOOK 220
10.3.2 GERMANY 229
10.3.2.1 Increasing prevalence of chronic diseases to propel market 229
10.3.3 UK 237
10.3.3.1 Initiatives by government to support market growth 237
10.3.4 FRANCE 245
10.3.4.1 Rising number of diagnostic imaging centers to drive market 245
10.3.5 ITALY 254
10.3.5.1 Availability of reimbursement coverage to support market growth 254
10.3.6 SPAIN 262
10.3.6.1 Increasing focus on cancer research to propel market 262
10.3.7 REST OF EUROPE 270
10.4 ASIA PACIFIC 278
10.4.1 MACROECONOMIC OUTLOOK 278
10.4.2 CHINA 289
10.4.2.1 Rapidly growing geriatric population to propel market 289
10.4.3 JAPAN 297
10.4.3.1 High adoption of advanced technologies to support market growth 297
10.4.4 INDIA 306
10.4.4.1 Rising prevalence of chronic diseases to drive market 306
10.4.5 AUSTRALIA 314
10.4.5.1 Increasing investments in research to provide opportunities for market growth 314
10.4.6 SOUTH KOREA 322
10.4.6.1 Presence of well-developed healthcare systems to propel market 322
10.4.7 REST OF ASIA PACIFIC 330
10.5 LATIN AMERICA 338
10.5.1 MACROECONOMIC OUTLOOK 339
10.5.2 BRAZIL 347
10.5.2.1 Favourable demographic conditions to drive market 347
10.5.3 MEXICO 356
10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market 356
10.5.4 REST OF LATIN AMERICA 364
10.6 MIDDLE EAST & AFRICA 372
10.6.1 MACROECONOMIC OUTLOOK 372
10.6.2 GCC COUNTRIES 381
10.6.2.1 Expansion of healthcare providers to drive growth 381
10.6.3 REST OF MIDDLE EAST & AFRICA 389
11 COMPETITIVE LANDSCAPE 397
11.1 OVERVIEW 397
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 397
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET 397
11.3 REVENUE ANALYSIS 399
11.4 MARKET SHARE ANALYSIS 399
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 402
11.5.1 STARS 402
11.5.2 EMERGING LEADERS 402
11.5.3 PERVASIVE PLAYERS 402
11.5.4 PARTICIPANTS 403
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 404
11.5.5.1 Company footprint 404
11.5.5.2 Region footprint 405
11.5.5.3 Product footprint 406
11.5.5.4 Technology footprint 407
11.5.5.5 Application footprint 408
11.5.5.6 End user footprint 409
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 410
11.6.1 PROGRESSIVE COMPANIES 410
11.6.2 RESPONSIVE COMPANIES 410
11.6.3 DYNAMIC COMPANIES 410
11.6.4 STARTING BLOCKS 410
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 411
11.7 COMPANY VALUATION & FINANCIAL METRICS 413
11.7.1 COMPANY VALUATION 413
11.7.2 FINANCIAL METRICS 413
11.8 BRAND/PRODUCT COMPARISON 414
11.9 COMPETITIVE SCENARIO 415
11.9.1 PRODUCT LAUNCHES & APPROVALS 415
11.9.2 DEALS 415
11.9.3 EXPANSIONS 416
12 COMPANY PROFILES 417
12.1 KEY PLAYERS 417
12.1.1 BD (BECTON, DICKINSON AND COMPANY) 417
12.1.1.1 Business overview 417
12.1.1.2 Products offered 419
12.1.1.3 Recent developments 427
12.1.1.3.1 Deals 427
12.1.1.4 MnM view 428
12.1.1.4.1 Key strengths 428
12.1.1.4.2 Strategic choices 428
12.1.1.4.3 Weaknesses & competitive threats 428
12.1.2 DEVICOR MEDICAL PRODUCTS, INC 429
12.1.2.1 Business overview 429
12.1.2.2 Products offered 430
12.1.2.3 Recent developments 433
12.1.2.3.1 Product launches & approvals 433
12.1.2.4 MnM view 433
12.1.2.4.1 Key strengths 433
12.1.2.4.2 Strategic choices 433
12.1.2.4.3 Weaknesses & competitive threats 434
12.1.3 MEDTRONIC 435
12.1.3.1 Business overview 435
12.1.3.2 Products offered 437
12.1.3.3 MnM view 438
12.1.3.3.1 Key strengths 438
12.1.3.3.2 Strategic choices 439
12.1.3.3.3 Weaknesses & competitive threats 439
12.1.4 CARDINAL HEALTH 440
12.1.4.1 Business overview 440
12.1.4.2 Products offered 442
12.1.4.3 MnM view 442
12.1.4.3.1 Key strengths 442
12.1.4.3.2 Strategic choices 442
12.1.4.3.3 Weaknesses & competitive threats 443
12.1.5 HOLOGIC, INC. 444
12.1.5.1 Business overview 444
12.1.5.2 Products offered 446
12.1.5.3 Recent developments 448
12.1.5.3.1 Deals 448
12.1.5.3.2 Other developments 449
12.1.5.4 MnM view 449
12.1.5.4.1 Key strengths 449
12.1.5.4.2 Strategic choices 449
12.1.5.4.3 Weaknesses & competitive threats 449
12.1.6 B. BRAUN SE 450
12.1.6.1 Business overview 450
12.1.6.2 Products offered 452
12.1.7 OLYMPUS CORPORATION 454
12.1.7.1 Business overview 454
12.1.7.2 Products offered 456
12.1.7.3 Recent developments 457
12.1.7.3.1 Deals 457
12.1.8 BOSTON SCIENTIFIC CORPORATION 458
12.1.8.1 Business overview 458
12.1.8.2 Products offered 460
12.1.9 FUJIFILM CORPORATION 462
12.1.9.1 Business overview 462
12.1.9.2 Products offered 464
12.1.10 STRYKER 465
12.1.10.1 Business overview 465
12.1.10.2 Products offered 466
12.1.11 TELEFLEX INCORPORATED 467
12.1.11.1 Business overview 467
12.1.11.2 Products offered 469
12.1.12 CONMED CORPORATION 470
12.1.12.1 Business overview 470
12.1.12.2 Products offered 472
12.1.13 MERIT MEDICAL SYSTEMS 474
12.1.13.1 Business overview 474
12.1.13.2 Products offered 476
12.1.14 JOHNSON & JOHNSON SERVICES, INC. 479
12.1.14.1 Business overview 479
12.1.14.2 Products offered 480
12.1.15 COOK GROUP 481
12.1.15.1 Business overview 481
12.1.15.2 Products offered 481
12.1.15.3 Recent developments 484
12.1.15.3.1 Product launches & approvals 484
12.2 OTHER PLAYERS 485
12.2.1 MICROPORT SCIENTIFIC CORPORATION 485
12.2.2 ARGON MEDICAL DEVICES 486
12.2.3 INRAD, INC. 487
12.2.4 SUMMIT MEDICAL LLC 488
12.2.5 TRANSMED7, LLC 489
12.2.6 DR. JAPAN CO., LTD. 490
12.2.7 IZI MEDICAL PRODUCTS 491
12.2.8 PLANMED OY 492
12.2.9 ADVIN HEALTH CARE 493
12.2.10 TRIVITRON HEALTHCARE 494
13 APPENDIX 495
13.1 DISCUSSION GUIDE 495
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 500
13.3 CUSTOMIZATION OPTIONS 502
13.4 RELATED REPORTS 502
13.5 AUTHOR DETAILS 503
LIST OF TABLES
TABLE 1 BIOPSY DEVICES MARKET: INCLUSIONS & EXCLUSIONS 44
TABLE 2 STANDARD CURRENCY CONVERSION RATE, 2019–2024 45
TABLE 3 RESEARCH ASSUMPTIONS 57
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 78
TABLE 5 BIOPSY DEVICES UNDER FDA’S REGULATION 21 CFR 876.1075 80
TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 11 LIST OF PATENTS IN BIOPSY DEVICES MARKET, 2014−2024 87
TABLE 12 IMPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION) 88
TABLE 13 EXPORT DATA FOR HS CODE 901831-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2019–2023 (USD MILLION) 88
TABLE 14 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD) 89
TABLE 15 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION,
2021–2023 (USD) 90
TABLE 16 BIOPSY DEVICES MARKET: KEY CONFERENCES & EVENTS, 2025 90
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 92
TABLE 18 KEY BUYING CRITERIA FOR KEY END USERS 92
TABLE 19 BIOPSY DEVICES MARKET: UNMET NEEDS 93
TABLE 20 BIOPSY DEVICES MARKET: EXPECTATIONS OF END USERS 93
TABLE 21 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 104
TABLE 22 BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 104
TABLE 23 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2021–2023 (USD MILLION) 105
TABLE 24 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2024–2030 (USD MILLION) 105
TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION) 106
TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION) 107
TABLE 27 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 108
TABLE 28 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 108
TABLE 29 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 109
TABLE 30 CORE NEEDLE BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 110
TABLE 31 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 111
TABLE 32 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 111
TABLE 33 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 112
TABLE 34 CORE NEEDLE BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 113
TABLE 35 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 115
TABLE 36 SEMI-AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 116
TABLE 37 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 117
TABLE 38 AUTOMATIC: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 118
TABLE 39 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 119
TABLE 40 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 119
TABLE 41 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 120
TABLE 42 CORE NEEDLE BIOPSY NEEDLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 121
TABLE 43 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 122
TABLE 44 DISPOSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 123
TABLE 45 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 124
TABLE 46 REUSABLE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 125
TABLE 47 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2021–2023 (USD MILLION) 126
TABLE 48 FINE NEEDLE ASPIRATION BIOPSY: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2024–2030 (USD MILLION) 127
TABLE 49 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 129
TABLE 50 VACUUM-ASSISTED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 130
TABLE 51 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 132
TABLE 52 VISUALIZATION DEVICE/SYSTEM: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 133
TABLE 53 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2021–2023 (USD MILLION) 134
TABLE 54 BRUSH BIOPSY INSTRUMENT: BIOPSY DEVICES MARKET, BY COUNTRY/ REGION, 2024–2030 (USD MILLION) 135
TABLE 55 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 136
TABLE 56 BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 136
TABLE 57 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 137
TABLE 58 BIOPSY ACCESSORY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 138
TABLE 59 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 139
TABLE 60 BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 139
TABLE 61 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 140
TABLE 62 BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 141
TABLE 63 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 142
TABLE 64 GENERAL BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 143
TABLE 65 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 144
TABLE 66 HOT BIOPSY FORECEP: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 145
TABLE 67 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 146
TABLE 68 TISSUE MARKER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 147
TABLE 69 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 148
TABLE 70 LOCALIZATION WIRE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 149
TABLE 71 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 150
TABLE 72 OTHER ACCESSORIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 151
TABLE 73 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 152
TABLE 74 ROBOTIC BIOPSY DEVICE: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 153
TABLE 75 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 155
TABLE 76 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 155
TABLE 77 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 156
TABLE 78 ULTRASOUND-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 157
TABLE 79 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 158
TABLE 80 STEREOTACTIC-GUIDED BIOPSY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 159
TABLE 81 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 160
TABLE 82 OTHER TECHNOLOGIES: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 161
TABLE 83 BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 163
TABLE 84 BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 163
TABLE 85 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION) 164
TABLE 86 ONCOLOGY: BIOPSY DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION) 164
TABLE 87 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 165
TABLE 88 ONCOLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 166
TABLE 89 BREAST CANCER: BIOPSY DEVICES CANCER MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 167
TABLE 90 BREAST CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 168
TABLE 91 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 169
TABLE 92 SOFT TISSUE CANCER: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 170
TABLE 93 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 171
TABLE 94 GASTROENTEROLOGY: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 172
TABLE 95 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 173
TABLE 96 BONE & BONE MARROW: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 174
TABLE 97 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 175
TABLE 98 OTHER APPLICATIONS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 176
TABLE 99 BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 178
TABLE 100 BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 178
TABLE 101 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2021–2023 (USD MILLION) 180
TABLE 102 HOSPITALS & BREAST CARE CENTERS: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2024–2030 (USD MILLION) 181
TABLE 103 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2021–2023 (USD MILLION) 183
TABLE 104 DIAGNOSTIC IMAGING CENTERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2024–2030 (USD MILLION) 184
TABLE 105 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2021–2023 (USD MILLION) 185
TABLE 106 AMBULATORY SURGICAL CENTERS: BIOPSY DEVICES MARKET,
BY COUNTRY/REGION, 2024–2030 (USD MILLION) 186
TABLE 107 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2021–2023 (USD MILLION) 187
TABLE 108 OTHER END USERS: BIOPSY DEVICES MARKET, BY COUNTRY/REGION,
2024–2030 (USD MILLION) 188
TABLE 109 BIOPSY DEVICES MARKET, BY REGION, 2021–2023 (USD MILLION) 191
TABLE 110 BIOPSY DEVICES MARKET, BY REGION, 2024–2030 (USD MILLION) 192
TABLE 111 BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2030 (THOUSAND UNITS) 193
TABLE 112 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 194
TABLE 113 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 195
TABLE 114 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 195
TABLE 115 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 195
TABLE 116 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 196
TABLE 117 NORTH AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 196
TABLE 118 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 196
TABLE 119 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 197
TABLE 120 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 197
TABLE 121 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 197
TABLE 122 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 198
TABLE 123 NORTH AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 198
TABLE 124 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 198
TABLE 125 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 199
TABLE 126 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 199
TABLE 127 NORTH AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 199
TABLE 128 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 200
TABLE 129 NORTH AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 200
TABLE 130 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 200
TABLE 131 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 201
TABLE 132 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 201
TABLE 133 NORTH AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 201
TABLE 134 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 202
TABLE 135 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 202
TABLE 136 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2030 (THOUSAND UNITS) 203
TABLE 137 US: MACRO-INDICATORS IMPACTING MARKET 204
TABLE 138 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 204
TABLE 139 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 205
TABLE 140 US: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2021–2023 (USD MILLION) 205
TABLE 141 US: BIOPSY DEVICES MARKET, BY NEEDLE BASED BIOPSY INSTRUMENT,
2024–2030 (USD MILLION) 205
TABLE 142 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 206
TABLE 143 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 206
TABLE 144 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 206
TABLE 145 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 207
TABLE 146 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 207
TABLE 147 US: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 207
TABLE 148 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 208
TABLE 149 US: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 208
TABLE 150 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 208
TABLE 151 US: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 209
TABLE 152 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 209
TABLE 153 US: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 209
TABLE 154 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 210
TABLE 155 US: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 210
TABLE 156 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 210
TABLE 157 US: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 211
TABLE 158 US: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 211
TABLE 159 US: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 211
TABLE 160 CANADA: MACRO-INDICATORS IMPACTING MARKET 212
TABLE 161 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 212
TABLE 162 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 213
TABLE 163 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 213
TABLE 164 CANADA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 213
TABLE 165 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 214
TABLE 166 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 214
TABLE 167 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 214
TABLE 168 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 215
TABLE 169 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 215
TABLE 170 CANADA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 215
TABLE 171 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 216
TABLE 172 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 216
TABLE 173 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 216
TABLE 174 CANADA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 217
TABLE 175 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 217
TABLE 176 CANADA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 217
TABLE 177 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 218
TABLE 178 CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 218
TABLE 179 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 218
TABLE 180 CANADA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 219
TABLE 181 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 219
TABLE 182 CANADA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 219
TABLE 183 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 220
TABLE 184 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 221
TABLE 185 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 221
TABLE 186 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 222
TABLE 187 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 222
TABLE 188 EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 222
TABLE 189 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 223
TABLE 190 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 223
TABLE 191 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 223
TABLE 192 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 224
TABLE 193 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 224
TABLE 194 EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 224
TABLE 195 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 225
TABLE 196 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 225
TABLE 197 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 225
TABLE 198 EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 226
TABLE 199 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 226
TABLE 200 EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 226
TABLE 201 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 227
TABLE 202 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 227
TABLE 203 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 227
TABLE 204 EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 228
TABLE 205 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 228
TABLE 206 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 228
TABLE 207 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2030 (THOUSAND UNITS) 229
TABLE 208 GERMANY: MACRO-INDICATORS IMPACTING MARKET 230
TABLE 209 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 230
TABLE 210 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 230
TABLE 211 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 231
TABLE 212 GERMANY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 231
TABLE 213 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 231
TABLE 214 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 232
TABLE 215 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 232
TABLE 216 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 232
TABLE 217 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 233
TABLE 218 GERMANY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 233
TABLE 219 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 233
TABLE 220 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 234
TABLE 221 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 234
TABLE 222 GERMANY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 234
TABLE 223 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 235
TABLE 224 GERMANY: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 235
TABLE 225 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 235
TABLE 226 GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 236
TABLE 227 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 236
TABLE 228 GERMANY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 236
TABLE 229 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 237
TABLE 230 GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 237
TABLE 231 UK: MACRO-INDICATORS IMPACTING MARKET 238
TABLE 232 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 238
TABLE 233 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 238
TABLE 234 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2021–2023 (USD MILLION) 239
TABLE 235 UK: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2024–2030 (USD MILLION) 239
TABLE 236 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 239
TABLE 237 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 240
TABLE 238 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 240
TABLE 239 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 240
TABLE 240 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 241
TABLE 241 UK: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 241
TABLE 242 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 241
TABLE 243 UK: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 242
TABLE 244 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 242
TABLE 245 UK: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 242
TABLE 246 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 243
TABLE 247 UK: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 243
TABLE 248 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 243
TABLE 249 UK: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 244
TABLE 250 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 244
TABLE 251 UK: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 244
TABLE 252 UK: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 245
TABLE 253 UK: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 245
TABLE 254 FRANCE: MACRO-INDICATORS IMPACTING GROWTH 246
TABLE 255 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 246
TABLE 256 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 247
TABLE 257 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 247
TABLE 258 FRANCE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 247
TABLE 259 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 248
TABLE 260 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 248
TABLE 261 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 248
TABLE 262 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 249
TABLE 263 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 249
TABLE 264 FRANCE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 249
TABLE 265 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 250
TABLE 266 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 250
TABLE 267 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 250
TABLE 268 FRANCE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 251
TABLE 269 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 251
TABLE 270 FRANCE: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 251
TABLE 271 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 252
TABLE 272 FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 252
TABLE 273 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 252
TABLE 274 FRANCE: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 253
TABLE 275 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 253
TABLE 276 FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 253
TABLE 277 ITALY: MACRO-INDICATORS IMPACTING MARKET 254
TABLE 278 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 254
TABLE 279 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 255
TABLE 280 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2021–2023 (USD MILLION) 255
TABLE 281 ITALY: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2024–2030 (USD MILLION) 255
TABLE 282 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 256
TABLE 283 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 256
TABLE 284 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 256
TABLE 285 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 257
TABLE 286 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 257
TABLE 287 ITALY: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 257
TABLE 288 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 258
TABLE 289 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 258
TABLE 290 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 258
TABLE 291 ITALY: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 259
TABLE 292 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 259
TABLE 293 ITALY: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 259
TABLE 294 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 260
TABLE 295 ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 260
TABLE 296 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 260
TABLE 297 ITALY: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 261
TABLE 298 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 261
TABLE 299 ITALY: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 261
TABLE 300 SPAIN: MACRO-INDICATORS IMPACTING MARKET 262
TABLE 301 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 262
TABLE 302 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 263
TABLE 303 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 263
TABLE 304 SPAIN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 263
TABLE 305 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 264
TABLE 306 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 264
TABLE 307 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 264
TABLE 308 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 265
TABLE 309 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 265
TABLE 310 SPAIN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 265
TABLE 311 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 266
TABLE 312 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 266
TABLE 313 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 266
TABLE 314 SPAIN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 267
TABLE 315 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 267
TABLE 316 SPAIN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 267
TABLE 317 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 268
TABLE 318 SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 268
TABLE 319 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 268
TABLE 320 SPAIN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 269
TABLE 321 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 269
TABLE 322 SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 269
TABLE 323 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 270
TABLE 324 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 271
TABLE 325 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 271
TABLE 326 REST OF EUROPE: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 271
TABLE 327 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 272
TABLE 328 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 272
TABLE 329 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 272
TABLE 330 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 273
TABLE 331 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 273
TABLE 332 REST OF EUROPE: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 273
TABLE 333 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 274
TABLE 334 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 274
TABLE 335 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 274
TABLE 336 REST OF EUROPE: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 275
TABLE 337 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 275
TABLE 338 REST OF EUROPE: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 275
TABLE 339 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 276
TABLE 340 REST OF EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 276
TABLE 341 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 276
TABLE 342 REST OF EUROPE: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 277
TABLE 343 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 277
TABLE 344 REST OF EUROPE: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 277
TABLE 345 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 280
TABLE 346 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 280
TABLE 347 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 281
TABLE 348 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 281
TABLE 349 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 282
TABLE 350 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 282
TABLE 351 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 282
TABLE 352 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 283
TABLE 353 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 283
TABLE 354 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 283
TABLE 355 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 284
TABLE 356 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 284
TABLE 357 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 284
TABLE 358 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 285
TABLE 359 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 285
TABLE 360 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 285
TABLE 361 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 286
TABLE 362 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 286
TABLE 363 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 286
TABLE 364 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 287
TABLE 365 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 287
TABLE 366 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 287
TABLE 367 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 288
TABLE 368 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 288
TABLE 369 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2030 (THOUSAND UNITS) 289
TABLE 370 CHINA: MACRO-INDICATORS IMPACTING MARKET 290
TABLE 371 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 290
TABLE 372 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 290
TABLE 373 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 291
TABLE 374 CHINA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 291
TABLE 375 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 291
TABLE 376 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 292
TABLE 377 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 292
TABLE 378 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 292
TABLE 379 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 293
TABLE 380 CHINA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 293
TABLE 381 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 293
TABLE 382 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 294
TABLE 383 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 294
TABLE 384 CHINA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 294
TABLE 385 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 295
TABLE 386 CHINA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 295
TABLE 387 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 295
TABLE 388 CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 296
TABLE 389 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 296
TABLE 390 CHINA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 296
TABLE 391 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 297
TABLE 392 CHINA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 297
TABLE 393 JAPAN: MACRO-INDICATORS IMPACTING MARKET 298
TABLE 394 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 298
TABLE 395 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 299
TABLE 396 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 299
TABLE 397 JAPAN: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 299
TABLE 398 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 300
TABLE 399 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 300
TABLE 400 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 300
TABLE 401 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 301
TABLE 402 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 301
TABLE 403 JAPAN: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 301
TABLE 404 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 302
TABLE 405 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 302
TABLE 406 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 302
TABLE 407 JAPAN: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 303
TABLE 408 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 303
TABLE 409 JAPAN: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 304
TABLE 410 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 304
TABLE 411 JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 305
TABLE 412 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 305
TABLE 413 JAPAN: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 305
TABLE 414 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 306
TABLE 415 JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 306
TABLE 416 INDIA: MACRO-INDICATORS IMPACTING GROWTH 307
TABLE 417 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 307
TABLE 418 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 307
TABLE 419 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2021–2023 (USD MILLION) 308
TABLE 420 INDIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2024–2030 (USD MILLION) 308
TABLE 421 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 308
TABLE 422 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 309
TABLE 423 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 309
TABLE 424 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 309
TABLE 425 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 310
TABLE 426 INDIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 310
TABLE 427 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 310
TABLE 428 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 311
TABLE 429 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 311
TABLE 430 INDIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 311
TABLE 431 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 312
TABLE 432 INDIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 312
TABLE 433 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 312
TABLE 434 INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 313
TABLE 435 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 313
TABLE 436 INDIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 313
TABLE 437 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 314
TABLE 438 INDIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 314
TABLE 439 AUSTRALIA: MACRO-INDICATORS IMPACTING MARKET 315
TABLE 440 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 315
TABLE 441 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 315
TABLE 442 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 316
TABLE 443 AUSTRALIA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 316
TABLE 444 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 316
TABLE 445 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 317
TABLE 446 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 317
TABLE 447 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 317
TABLE 448 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 318
TABLE 449 AUSTRALIA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 318
TABLE 450 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 318
TABLE 451 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 319
TABLE 452 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 319
TABLE 453 AUSTRALIA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 319
TABLE 454 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 320
TABLE 455 AUSTRALIA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 320
TABLE 456 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 320
TABLE 457 AUSTRALIA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 321
TABLE 458 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 321
TABLE 459 AUSTRALIA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 321
TABLE 460 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 322
TABLE 461 AUSTRALIA: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 322
TABLE 462 SOUTH KOREA: MACRO-INDICATORS IMPACTING MARKET 323
TABLE 463 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 323
TABLE 464 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 323
TABLE 465 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 324
TABLE 466 SOUTH KOREA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 324
TABLE 467 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 324
TABLE 468 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 325
TABLE 469 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 325
TABLE 470 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 325
TABLE 471 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 326
TABLE 472 SOUTH KOREA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 326
TABLE 473 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 326
TABLE 474 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 327
TABLE 475 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 327
TABLE 476 SOUTH KOREA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 327
TABLE 477 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 328
TABLE 478 SOUTH KOREA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 328
TABLE 479 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 328
TABLE 480 SOUTH KOREA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 329
TABLE 481 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 329
TABLE 482 SOUTH KOREA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 329
TABLE 483 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 330
TABLE 484 SOUTH KOREA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 330
TABLE 485 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 331
TABLE 486 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 331
TABLE 487 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 332
TABLE 488 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 332
TABLE 489 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 332
TABLE 490 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 333
TABLE 491 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 333
TABLE 492 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 333
TABLE 493 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 334
TABLE 494 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 334
TABLE 495 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 334
TABLE 496 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 335
TABLE 497 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 335
TABLE 498 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 335
TABLE 499 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 336
TABLE 500 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 336
TABLE 501 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 336
TABLE 502 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 337
TABLE 503 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 337
TABLE 504 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 337
TABLE 505 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 338
TABLE 506 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 338
TABLE 507 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 339
TABLE 508 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 339
TABLE 509 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 340
TABLE 510 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 340
TABLE 511 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 340
TABLE 512 LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 341
TABLE 513 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 341
TABLE 514 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 341
TABLE 515 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 342
TABLE 516 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 342
TABLE 517 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 342
TABLE 518 LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 343
TABLE 519 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 343
TABLE 520 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 343
TABLE 521 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 344
TABLE 522 LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 344
TABLE 523 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 344
TABLE 524 LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 345
TABLE 525 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 345
TABLE 526 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 345
TABLE 527 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 346
TABLE 528 LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 346
TABLE 529 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 346
TABLE 530 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 347
TABLE 531 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2030 (THOUSAND UNITS) 347
TABLE 532 BRAZIL: MACRO-INDICATORS IMPACTING MARKET 348
TABLE 533 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 348
TABLE 534 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 349
TABLE 535 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 349
TABLE 536 BRAZIL: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 349
TABLE 537 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 350
TABLE 538 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 350
TABLE 539 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 350
TABLE 540 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 351
TABLE 541 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 351
TABLE 542 BRAZIL: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 351
TABLE 543 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 352
TABLE 544 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 352
TABLE 545 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 352
TABLE 546 BRAZIL: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 353
TABLE 547 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 353
TABLE 548 BRAZIL: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 353
TABLE 549 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 354
TABLE 550 BRAZIL: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 354
TABLE 551 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 354
TABLE 552 BRAZIL: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 355
TABLE 553 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 355
TABLE 554 BRAZIL: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 355
TABLE 555 MEXICO: MACRO-INDICATORS IMPACTING MARKET 356
TABLE 556 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021–2023 (USD MILLION) 357
TABLE 557 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2024–2030 (USD MILLION) 357
TABLE 558 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 357
TABLE 559 MEXICO: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 358
TABLE 560 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 358
TABLE 561 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 358
TABLE 562 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2021–2023 (USD MILLION) 359
TABLE 563 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE,
2024–2030 (USD MILLION) 359
TABLE 564 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2021–2023 (USD MILLION) 359
TABLE 565 MEXICO: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE,
2024–2030 (USD MILLION) 360
TABLE 566 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 360
TABLE 567 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 360
TABLE 568 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 361
TABLE 569 MEXICO: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 361
TABLE 570 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 361
TABLE 571 MEXICO: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 362
TABLE 572 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 362
TABLE 573 MEXICO: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 362
TABLE 574 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 363
TABLE 575 MEXICO: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 363
TABLE 576 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION) 363
TABLE 577 MEXICO: BIOPSY DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION) 364
TABLE 578 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 364
TABLE 579 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 365
TABLE 580 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 365
TABLE 581 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 365
TABLE 582 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 366
TABLE 583 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 366
TABLE 584 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 366
TABLE 585 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 367
TABLE 586 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 367
TABLE 587 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 367
TABLE 588 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 368
TABLE 589 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 368
TABLE 590 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 368
TABLE 591 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 369
TABLE 592 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 369
TABLE 593 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 369
TABLE 594 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 370
TABLE 595 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 370
TABLE 596 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 370
TABLE 597 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 371
TABLE 598 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 371
TABLE 599 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 371
TABLE 600 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2021–2023 (USD MILLION) 372
TABLE 601 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY COUNTRY,
2024–2030 (USD MILLION) 372
TABLE 602 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 373
TABLE 603 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 373
TABLE 604 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 374
TABLE 605 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 374
TABLE 606 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 374
TABLE 607 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 375
TABLE 608 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 375
TABLE 609 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 375
TABLE 610 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 376
TABLE 611 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 376
TABLE 612 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 376
TABLE 613 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 377
TABLE 614 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 377
TABLE 615 MIDDLE EAST &AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 377
TABLE 616 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 378
TABLE 617 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 378
TABLE 618 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 378
TABLE 619 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 379
TABLE 620 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 379
TABLE 621 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 379
TABLE 622 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 380
TABLE 623 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 380
TABLE 624 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2030 (THOUSAND UNITS) 381
TABLE 625 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 382
TABLE 626 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 382
TABLE 627 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 382
TABLE 628 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 383
TABLE 629 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2021–2023 (USD MILLION) 383
TABLE 630 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024–2030 (USD MILLION) 383
TABLE 631 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 384
TABLE 632 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 384
TABLE 633 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 384
TABLE 634 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 385
TABLE 635 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2021–2023 (USD MILLION) 385
TABLE 636 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY,
2024–2030 (USD MILLION) 385
TABLE 637 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2021–2023 (USD MILLION) 386
TABLE 638 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP,
2024–2030 (USD MILLION) 386
TABLE 639 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2021–2023 (USD MILLION) 386
TABLE 640 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY TECHNOLOGY,
2024–2030 (USD MILLION) 387
TABLE 641 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION,
2021–2023 (USD MILLION) 387
TABLE 642 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY APPLICATION,
2024–2030 (USD MILLION) 387
TABLE 643 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2021–2023 (USD MILLION) 388
TABLE 644 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY ONCOLOGY,
2024–2030 (USD MILLION) 388
TABLE 645 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 388
TABLE 646 GCC COUNTRIES: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 389
TABLE 647 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2021–2023 (USD MILLION) 389
TABLE 648 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT,
2024–2030 (USD MILLION) 390
TABLE 649 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2021–2023 (USD MILLION) 390
TABLE 650 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT, 2024–2030 (USD MILLION) 390
TABLE 651 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2021–2023 (USD MILLION) 391
TABLE 652 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY, 2024–2030 (USD MILLION) 391
TABLE 653 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2021–2023 (USD MILLION) 391
TABLE 654 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY DEVICE, 2024–2030 (USD MILLION) 392
TABLE 655 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2021–2023 (USD MILLION) 392
TABLE 656 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY NEEDLE, 2024–2030 (USD MILLION) 392
TABLE 657 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2021–2023 (USD MILLION) 393
TABLE 658 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY ACCESSORY, 2024–2030 (USD MILLION) 393
TABLE 659 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2021–2023 (USD MILLION) 393
TABLE 660 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY BIOPSY FORECEP, 2024–2030 (USD MILLION) 394
TABLE 661 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2021–2023 (USD MILLION) 394
TABLE 662 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024–2030 (USD MILLION) 394
TABLE 663 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION) 395
TABLE 664 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION) 395
TABLE 665 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2021–2023 (USD MILLION) 395
TABLE 666 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY ONCOLOGY, 2024–2030 (USD MILLION) 396
TABLE 667 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,
2021–2023 (USD MILLION) 396
TABLE 668 REST OF MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER,
2024–2030 (USD MILLION) 396
TABLE 669 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOPSY DEVICES MARKET 397
TABLE 670 BIOPSY DEVICES MARKET: DEGREE OF COMPETITION 400
TABLE 671 BIOPSY DEVICES MARKET: REGION FOOTPRINT 405
TABLE 672 BIOPSY DEVICES MARKET: PRODUCT FOOTPRINT 406
TABLE 673 BIOPSY DEVICES MARKET: TECHNOLOGY FOOTPRINT 407
TABLE 674 BIOPSY DEVICES MARKET: APPLICATION FOOTPRINT 408
TABLE 675 BIOPSY DEVICES MARKET: END USER FOOTPRINT 409
TABLE 676 BIOPSY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 411
TABLE 677 BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 412
TABLE 678 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 415
TABLE 679 BIOPSY DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025 415
TABLE 680 BIOPSY DEVICES MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 416
TABLE 681 BD (BECTON, DICKINSON AND COMPANY): COMPANY OVERVIEW 417
TABLE 682 BD (BECTON, DICKINSON AND COMPANY): PRODUCTS OFFERED 419
TABLE 683 BD (BECTON, DICKINSON AND COMPANY): DEALS, JANUARY 2021–JANUARY 2025 427
TABLE 684 DEVICOR MEDICAL PRODUCTS, INC: COMPANY OVERVIEW 429
TABLE 685 DEVICOR MEDICAL PRODUCTS, INC: PRODUCTS OFFERED 430
TABLE 686 DEVICOR MEDICAL PRODUCTS, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025 433
TABLE 687 MEDTRONIC: COMPANY OVERVIEW 435
TABLE 688 MEDTRONIC: PRODUCTS OFFERED 437
TABLE 689 CARDINAL HEALTH: COMPANY OVERVIEW 440
TABLE 690 CARDINAL HEALTH: PRODUCTS OFFERED 442
TABLE 691 HOLOGIC, INC.: COMPANY OVERVIEW 444
TABLE 692 HOLOGIC, INC: PRODUCTS OFFERED 446
TABLE 693 HOLOGIC, INC: DEALS, JANUARY 2021–JANUARY 2025 448
TABLE 694 B. BRAUN SE: COMPANY OVERVIEW 450
TABLE 695 B. BRAUN SE: PRODUCTS OFFERED 452
TABLE 696 OLYMPUS CORPORATION: COMPANY OVERVIEW 454
TABLE 697 OLYMPUS CORPORATION: PRODUCTS OFFERED 456
TABLE 698 OLYMPUS CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 457
TABLE 699 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 458
TABLE 700 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 460
TABLE 701 FUJIFILM CORPORATION: COMPANY OVERVIEW 462
TABLE 702 FUJIFILM CORPORATION: PRODUCTS OFFERED 464
TABLE 703 STRYKER: COMPANY OVERVIEW 465
TABLE 704 STRYKER: PRODUCTS OFFERED 466
TABLE 705 TELEFLEX INCORPORATED: COMPANY OVERVIEW 467
TABLE 706 TELEFLEX INCORPORATED: PRODUCTS OFFERED 469
TABLE 707 CONMED CORPORATION: COMPANY OVERVIEW 470
TABLE 708 CONMED CORPORATION: PRODUCTS OFFERED 472
TABLE 709 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 474
TABLE 710 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 476
TABLE 711 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 478
TABLE 712 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021–JANUARY 2025 478
TABLE 713 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 479
TABLE 714 JOHNSON & JOHNSON SERVICES INC.: PRODUCTS OFFERED 480
TABLE 715 COOK GROUP: COMPANY OVERVIEW 481
TABLE 716 COOK GROUP: PRODUCTS OFFERED 481
TABLE 717 COOK GROUP: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 484
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 47
FIGURE 2 PRIMARY SOURCES 50
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 52
FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 53
FIGURE 5 TOP-DOWN APPROACH 53
FIGURE 6 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
FIGURE 7 BIOPSY DEVICES MARKET: CAGR PROJECTIONS 55
FIGURE 8 DATA TRIANGULATION METHODOLOGY 57
FIGURE 9 BIOPSY DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION) 59
FIGURE 10 BIOPSY DEVICES MARKET, BY NEEDLE-BASED BIOPSY INSTRUMENT,
2024 VS. 2030 (USD MILLION) 60
FIGURE 11 BIOPSY DEVICES MARKET, BY CORE NEEDLE BIOPSY,
2024 VS. 2030 (USD MILLION) 60
FIGURE 12 BIOPSY DEVICES MARKET, BY TECHNOLOGY, 2024 VS. 2030 (USD MILLION) 61
FIGURE 13 BIOPSY DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 61
FIGURE 14 BIOPSY DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 62
FIGURE 15 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 63
FIGURE 16 RISING CASES OF CANCER TO DRIVE GLOBAL ADOPTION OF BIOPSY DEVICES 64
FIGURE 17 US AND HOSPITALS & BREAST CARE CENTERS SEGMENT ACCOUNTED FOR SIGNIFICANT SHARE IN 2023 65
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 66
FIGURE 19 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 67
FIGURE 20 DEVELOPING MARKET SEGMENT TO REGISTER HIGHER GROWTH THAN DEVELOPED MARKET SEGMENT BY 2030 67
FIGURE 21 BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 68
FIGURE 22 TRENDS IN BIOPSY DEVICES MARKET 73
FIGURE 23 BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 79
FIGURE 24 NUMBER OF PATENTS PUBLISHED, 2014–2025 85
FIGURE 25 TOP TEN PATENT OWNERS FOR BIOPSY DEVICES, 2014−2025 86
FIGURE 26 TOP APPLICANTS FOR BIOPSY DEVICES, 2014−2025 86
FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY KEY PRODUCT, 2021–2023 (USD) 89
FIGURE 28 AVERAGE SELLING PRICE TREND OF BIOPSY DEVICES, BY REGION,
2021–2023 (USD) 90
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 91
FIGURE 30 KEY BUYING CRITERIA FOR KEY END USERS 92
FIGURE 31 BIOPSY DEVICES MARKET: ECOSYSTEM ANALYSIS 94
FIGURE 32 BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS 98
FIGURE 33 REVENUE SHIFT FOR BIOPSY DEVICES MARKET 100
FIGURE 34 INVESTMENT & FUNDING SCENARIO, 2019–2023 (USD MILLION) 101
FIGURE 35 USE OF AI/GEN AI IN BIOPSY PROCEDURES 102
FIGURE 36 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT 194
FIGURE 37 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT 279
FIGURE 38 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION) 399
FIGURE 39 MARKET SHARE ANALYSIS, 2023 400
FIGURE 40 RANKING OF KEY PLAYERS IN BIOPSY DEVICES MARKET, 2023 402
FIGURE 41 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 403
FIGURE 42 BIOPSY DEVICES MARKET: COMPANY FOOTPRINT 404
FIGURE 43 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2023 411
FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 413
FIGURE 45 EV/EBITDA OF KEY PLAYERS 413
FIGURE 46 BIOPSY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 414
FIGURE 47 BD (BECTON, DICKINSON AND COMPANY): COMPANY SNAPSHOT (2024) 418
FIGURE 48 DEVICOR MEDICAL PRODUCTS, INC: COMPANY SNAPSHOT (2023) 430
FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024) 436
FIGURE 50 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 441
FIGURE 51 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 445
FIGURE 52 B. BRAUN SE: COMPANY SNAPSHOT (2023) 451
FIGURE 53 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 455
FIGURE 54 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 459
FIGURE 55 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 463
FIGURE 56 STRYKER: COMPANY SNAPSHOT (2023) 466
FIGURE 57 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2023) 468
FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 471
FIGURE 59 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023) 475
FIGURE 60 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023) 480
MarketsandMarkets(マーケッツアンドマーケッツ)は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間~12時間以内(営業日基準)にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
シングルユーザ | コーポレート |
USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連会社除く)5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100%持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内(営業日基準)
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- UV安定剤市場 – 2030年までの世界予測 2025-05-16
- 産業用通信市場 – 2030年までの世界予測 2025-05-16
- 経腸栄養装置市場 – 2030年までの世界予測 2025-05-15
- データセンターGPU市場 – 2030年までの世界予測 2025-05-15
- ステンレス鋼シームレスパイプ市場 – 2030年までの世界予測 2025-05-15